Tolterodine Extended Release With or Without Tamsulosin in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms: Effects of Prostate Size-Reference-Cited by-同舟云学术

Tolterodine Extended Release With or Without Tamsulosin in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms: Effects of Prostate Size

Published:2009-02 Issue:2 Volume:55 Page:472-481
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Roehrborn Claus G.,Kaplan Steven A.,Jones J. Stephen,Wang Joseph T.,Bavendam Tamara,Guan Zhonghong

Publisher

Elsevier BV

Subject

Urology

Reference29 articles.

1. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society;Abrams;Urology,2003

2. A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder;Chapple;Eur Urol,2006

3. The development of human benign prostatic hyperplasia with age;Berry;J Urol,1984

4. The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study;Boyle;BJU Int,2003

5. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study;Irwin;Eur Urol,2006

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravesical Injection of Botulinum Toxin Type A in Men without Bladder Outlet Obstruction and Post-Deobstructive Prostate Surgery;Toxins;2023-03-15

2. Role of Antimuscarinics Combined With Alpha-blockers in the Management of Urinary Storage Symptoms in Patients With Benign Prostatic Hyperplasia: An Updated Systematic Review and Meta-analysis;Journal of Urology;2023-02

3. Comparative Efficacy of Different Drugs for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia: A Bayesian Network Meta-Analysis;Frontiers in Pharmacology;2022-03-07

4. Efficacy and safety of onabotulinumtoxinA in patients with overactive bladder: subgroup analyses by sex and by serum prostate-specific antigen levels in men from a randomized controlled trial;International Urology and Nephrology;2021-07-22

5. Detrusor Overactivity May Be a Prognostic Factor for Better Response to Combination Therapy Over Monotherapy in Male Patients With Benign Prostatic Enlargement and Storage Lower Urinary Tract Symptoms;International Neurourology Journal;2021-03-31